Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$33K Sell
657
-1
-0.2% -$49 0.3% 26
2015
Q4
$33K Sell
658
-1,029
-61% -$51.9K 0.3% 28
2015
Q3
$80K Sell
1,687
-1,197,437
-100% -$63.6M 0.74% 26
2015
Q2
$65.1M Buy
1,199,124
+130,597
+12% +$7.32M 0.88% 21
2015
Q1
$58.6M Sell
1,068,527
-66,008
-6% -$3.74M 0.88% 17
2014
Q4
$61.5M Buy
1,134,535
+77,088
+7% +$4.29M 0.88% 20
2014
Q3
$59.8M Sell
1,057,447
-13,196
-1% -$741K 0.97% 18
2014
Q2
$59.1M Buy
1,070,643
+59,329
+6% +$3.24M 0.95% 16
2014
Q1
$54.8M Sell
1,011,314
-69,062
-6% -$3.58M 0.98% 17
2013
Q4
$51.6M Buy
1,080,376
+30,332
+3% +$1.39M 0.87% 19
2013
Q3
$47.7M Sell
1,050,044
-28,979
-3% -$1.32M 0.91% 19
2013
Q2
$47.8M Buy
+1,079,023
New +$48.2M 0.95% 19

Other funds holding MRK

TD Securities (USA)'s MRK Position: Q1 2016 in Review

TD Securities (USA) reduced its Merck (MRK) stake by 0.15% in Q1 2016, selling an estimated $49 and leaving 657 shares worth $33K. The position accounts for 0.3% of the portfolio, ranked #26.

TD Securities (USA) first reported a position in MRK in Q2 2013 and has held it in 12 quarters since. The position peaked at $65.1M in Q2 2015. 1,745 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • TD Securities (USA) held 657 shares of Merck worth $33K as of Q1 2016.
  • TD Securities (USA) sold 1 Merck share in Q1 2016, an estimated $49.
  • Merck made up 0.3% of TD Securities (USA)'s portfolio in Q1 2016, its #26 holding.
  • TD Securities (USA) first reported a position in Merck in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Merck position peaked at $65.1M in Q2 2015.
  • 1,745 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.